Biocartis Announces Successful Rights Offering: Existing Shareholders and New Investors Fully Subscribed for the Rights Offering Following Successful Private Placement of the Scrips and Backstop Undertakings
Biocartis Announces 55.91% of Offered Shares Subscribed at Closing of the Rights Subscription Period for Holders of Preferential Rights, and Start of the Sale of the Scrips through a Private Placement to Institutional Investors